Cephalexin concentrations in radicular granuloma following a single oral administration of 250- or 500-mg cephalexin. 1994

Y Akimoto, and A Uda, and H Omata, and J Shibutani, and H Nishimura, and M Komiya, and T Kawana, and K Kaneko, and A Fujii, and T Kaneda
Department of Oral Surgery 2, Nihon University School of Dentistry at Matsudo, Chiba, Japan.

1. Cephalexin concentrations in radicular granuloma and serum following a single oral administration of 250- or 500-mg cephalexin were measured by a paper disk method. 2. The highest concentration of cephalexin in radicular granuloma following administration of 250-mg cephalexin to nonfasting patients was observed at 2 hr, and was 1.62 micrograms/g. The mean cephalexin concentration ratio of radicular granuloma/serum at 2 hr was 0.35. 3. The highest concentrations of cephalexin in radicular granuloma following administration of 500-mg cephalexin to nonfasting and fasting patients occurred at 2 and 1.5 hr, and was 3.35 and 3.42 micrograms/g, respectively. Mean cephalexin concentration ratios of radicular granuloma/serum at 2 and 1.5 hr were 0.32 and 0.30, respectively. 4. All mean cephalexin concentrations in radicular granuloma following administration of 500-mg cephalexin to both fasting and nonfasting patients exceeded MIC for 90% (2 micrograms/ml) of clinically isolated strains of alpha-hemolytic streptococci. However, those concentrations obtained by 250-mg cephalexin did not exceed it.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D010484 Periapical Granuloma Chronic nonsuppurative inflammation of periapical tissue resulting from irritation following pulp disease or endodontic treatment. Dental Granuloma,Granuloma, Periapical,Periapical Periodontitis, Chronic Nonsuppurative,Periodontitis, Apical, Chronic Nonsuppurative,Dental Granulomas,Granuloma, Dental,Granulomas, Dental,Granulomas, Periapical,Periapical Granulomas
D002506 Cephalexin A semisynthetic cephalosporin antibiotic with antimicrobial activity similar to that of CEPHALORIDINE or CEPHALOTHIN, but somewhat less potent. It is effective against both gram-positive and gram-negative organisms. 5-Thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid, 7-((aminophenylacetyl)amino)-3-methyl-8-oxo-, (6R-(6alpha,7beta(R*)))-,Cefalexin,Cephalexin Dihydride,Cephalexin Hemihydrate,Cephalexin Hydrochloride,Cephalexin Monohydrate,Cephalexin Monohydrochloride,Cephalexin Monohydrochloride, Monohydrate,Cephalexin, (6R-(6alpha,7alpha(R*)))-Isomer,Cephalexin, (6R-(6alpha,7beta(S*)))-Isomer,Cephalexin, (6R-(6alpha,7beta))-Isomer,Cephalexin, Monosodium Salt,Cephalexin, Monosodium Salt, (6R-(6alpha,7beta))-Isomer,Ceporexine,Palitrex
D005215 Fasting Abstaining from FOOD. Hunger Strike,Hunger Strikes,Strike, Hunger,Strikes, Hunger
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults

Related Publications

Y Akimoto, and A Uda, and H Omata, and J Shibutani, and H Nishimura, and M Komiya, and T Kawana, and K Kaneko, and A Fujii, and T Kaneda
January 1992, Journal of oral and maxillofacial surgery : official journal of the American Association of Oral and Maxillofacial Surgeons,
Y Akimoto, and A Uda, and H Omata, and J Shibutani, and H Nishimura, and M Komiya, and T Kawana, and K Kaneko, and A Fujii, and T Kaneda
May 1996, Biopharmaceutics & drug disposition,
Y Akimoto, and A Uda, and H Omata, and J Shibutani, and H Nishimura, and M Komiya, and T Kawana, and K Kaneko, and A Fujii, and T Kaneda
January 1996, Sexually transmitted diseases,
Y Akimoto, and A Uda, and H Omata, and J Shibutani, and H Nishimura, and M Komiya, and T Kawana, and K Kaneko, and A Fujii, and T Kaneda
August 1998, General pharmacology,
Y Akimoto, and A Uda, and H Omata, and J Shibutani, and H Nishimura, and M Komiya, and T Kawana, and K Kaneko, and A Fujii, and T Kaneda
January 1994, The Journal of antimicrobial chemotherapy,
Y Akimoto, and A Uda, and H Omata, and J Shibutani, and H Nishimura, and M Komiya, and T Kawana, and K Kaneko, and A Fujii, and T Kaneda
December 2019, International journal of clinical pharmacology and therapeutics,
Y Akimoto, and A Uda, and H Omata, and J Shibutani, and H Nishimura, and M Komiya, and T Kawana, and K Kaneko, and A Fujii, and T Kaneda
May 1998, Biopharmaceutics & drug disposition,
Y Akimoto, and A Uda, and H Omata, and J Shibutani, and H Nishimura, and M Komiya, and T Kawana, and K Kaneko, and A Fujii, and T Kaneda
March 1999, The Journal of antimicrobial chemotherapy,
Y Akimoto, and A Uda, and H Omata, and J Shibutani, and H Nishimura, and M Komiya, and T Kawana, and K Kaneko, and A Fujii, and T Kaneda
April 1988, Genitourinary medicine,
Y Akimoto, and A Uda, and H Omata, and J Shibutani, and H Nishimura, and M Komiya, and T Kawana, and K Kaneko, and A Fujii, and T Kaneda
December 2006, International journal of antimicrobial agents,
Copied contents to your clipboard!